Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial.
about
Interventions for enhancing medication adherenceStavudine or zidovudine in three-drug combination therapy for initial treatment of HIV infection in antiretroviral-naïve individualsInterventions for enhancing medication adherenceViral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic reviewHIV/AIDS and lipodystrophy: implications for clinical management in resource-limited settingsHIV-1 subtype C-infected individuals maintaining high viral load as potential targets for the "test-and-treat" approach to reduce HIV transmissionEffect of micronutrient supplementation on disease progression in asymptomatic, antiretroviral-naive, HIV-infected adults in Botswana: a randomized clinical trialDo HIV-1 non-B subtypes differentially impact resistance mutations and clinical disease progression in treated populations? Evidence from a systematic review.The development of simple anthropometric measures to diagnose antiretroviral therapy-associated lipodystrophy in resource limited settingsSecond-line antiretroviral therapy in a workplace and community-based treatment programme in South Africa: determinants of virological outcomeAntiretroviral regimens in pregnancy and breast-feeding in Botswana.A randomized factorial trial comparing 4 treatment regimens in treatment-naive HIV-infected persons with AIDS and/or a CD4 cell count <200 cells/μL in South Africa.First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial.Regional anthropometry changes in antiretroviral-naïve persons initiating a Zidovudine-containing regimen in Mbarara, Uganda.Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America.HIV-Antiretroviral Therapy Induced Liver, Gastrointestinal, and Pancreatic Injury.Plasma drug level validates self-reported adherence but predicts limited specificity for nonadherence to antiretroviral therapyInitial virologic response and HIV drug resistance among HIV-infected individuals initiating first-line antiretroviral therapy at 2 clinics in Chennai and Mumbai, IndiaHIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countries.Tenofovir in second-line ART in Zambia and South Africa: collaborative analysis of cohort studiesValidation of A Point-of-Care Lactate Device For Screening At-Risk Adults Receiving Combination Antiretroviral Therapy In BotswanaTSCQ study: a randomized, controlled, open-label trial of daily trimethoprim-sulfamethoxazole or weekly chloroquine among adults on antiretroviral therapy in Malawi: study protocol for a randomized controlled trialZidovudine impairs immunological recovery on first-line antiretroviral therapy: collaborative analysis of cohort studies in southern Africa.Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges.Community-Based Interventions to Improve and Sustain Antiretroviral Therapy Adherence, Retention in HIV Care and Clinical Outcomes in Low- and Middle-Income Countries for Achieving the UNAIDS 90-90-90 TargetsHIV testing and antiretroviral treatment strategies for prevention of HIV infection: impact on antiretroviral drug resistance.Projecting the epidemiological effect, cost-effectiveness and transmission of HIV drug resistance in Vietnam associated with viral load monitoring strategies.Effect of BMI and fat mass on HIV disease progression in HIV-infected, antiretroviral treatment-naïve adults in Botswana.Reductions in virological failure and drug resistance in Chinese antiretroviral-treated patients due to lamivudine-based regimens, 2003-12.Long-term effectiveness and safety of didanosine combined with lamivudine and efavirenz or nevirapine in antiretroviral-naive patients: a 9-year cohort study in Senegal.The effect of micronutrient supplementation on active TB incidence early in HIV infection in Botswana.
P2860
Q24187912-A19D02EE-A466-4332-AE37-B7A97FEA7C86Q24236476-A306313D-996E-4741-AD88-CA2456C51678Q24243296-04BC9007-A0BA-4DA1-ADD8-29D5D21D1E1CQ26823588-200188F4-0E6E-4D2A-BECE-AD7DF017C11BQ28088839-FC053CFB-4024-4941-A4CE-646BC67898C9Q28473637-3113371C-5B83-4233-90D3-4D4F5B8BDB9DQ30624220-F966E372-71F0-4873-B383-45592B025635Q33850909-3CD2C0D1-0819-409D-991C-AF3E3D801012Q34067682-609436B0-988F-4080-9016-80366D351D74Q34292437-457DAADE-6888-4422-9FEF-61DE93ECDFAAQ34395082-DBB1B06B-05FA-4626-84D9-09FB62D1F3F4Q34431819-720EC9A1-4310-47AE-B37D-3B18DD9FA76BQ34748599-A0AAED3D-AF8F-44C7-96C6-BDF6D9D061B3Q35173638-543CE28E-3B04-4539-95A7-F30FCBFDD764Q35800140-D6C6BC55-2235-42F5-A0E3-E7677937EBDDQ35852627-9E098AF4-ED2F-423D-8F38-BDC6A2F8D927Q35863974-1FBE5171-D3DD-4E8C-A07F-E7AC089E5395Q35917573-8D73B709-CE7B-4D71-A69C-426E2CDA8DE5Q35917583-5329859E-BB49-480E-A219-24DC10AF3391Q36204098-3167BF5E-3C6F-420A-B1DE-4ADE8E2739A6Q36329990-1E394752-A27E-45C7-97A3-915699A1C525Q37108386-2E017293-F338-4EA6-9612-B4130627DAE9Q37274485-BE9F4887-03E0-4FC6-B5FB-F50B9271764AQ37415603-1124F780-FA8B-41FE-88BA-157DF1D69897Q37710293-7014909F-929F-4F23-8130-90C254085C7FQ37935116-01859565-A357-40D3-9619-C00B935CE5BBQ40002754-63C02E21-0270-4C9B-80DA-A58834CEBAEAQ40710920-9F3EB5FC-197E-437B-9FA2-758E239DC5F1Q42149889-9D102077-28A6-47B3-A0EB-BEB1BD7EA6EEQ43414255-E9B28AC5-6460-4E66-BFC2-669C147AB75FQ47159987-C63339AD-2F0D-41F3-8BF9-93195459FD40
P2860
Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Response to zidovudine/didanos ...... m a randomized clinical trial.
@ast
Response to zidovudine/didanos ...... m a randomized clinical trial.
@en
Response to zidovudine/didanos ...... m a randomized clinical trial.
@nl
type
label
Response to zidovudine/didanos ...... m a randomized clinical trial.
@ast
Response to zidovudine/didanos ...... m a randomized clinical trial.
@en
Response to zidovudine/didanos ...... m a randomized clinical trial.
@nl
prefLabel
Response to zidovudine/didanos ...... m a randomized clinical trial.
@ast
Response to zidovudine/didanos ...... m a randomized clinical trial.
@en
Response to zidovudine/didanos ...... m a randomized clinical trial.
@nl
P2093
P2860
P50
P1476
Response to zidovudine/didanos ...... m a randomized clinical trial.
@en
P2093
Ann Thomas
C William Wester
Erik Widenfelt
Hermann Bussmann
Howard Moffat
Madisa Mine
Ndwapi Ndwapi
Norah Mawoko
Reginald Okezie
Richard G Marlink
P2860
P356
10.1097/QAI.0B013E31819FF102
P407
P577
2009-05-01T00:00:00Z